Nuveen Asset Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4.5M | Sell |
181,636
-2,960
| -2% | -$73.4K | ﹤0.01% | 2029 |
|
|
2024
Q3 | $4.52M | Hold |
184,596
| – | – | ﹤0.01% | 2036 |
|
|
2024
Q2 | $4.33M | Buy |
184,596
+10,405
| +6% | +$244K | ﹤0.01% | 2027 |
|
|
2024
Q1 | $5.76M | Sell |
174,191
-3,444
| -2% | -$114K | ﹤0.01% | 1913 |
|
|
2023
Q4 | $4.84M | Sell |
177,635
-3,055
| -2% | -$83.2K | ﹤0.01% | 1998 |
|
|
2023
Q3 | $4.35M | Buy |
180,690
+9,606
| +6% | +$231K | ﹤0.01% | 1936 |
|
|
2023
Q2 | $5.46M | Sell |
171,084
-30,057
| -15% | -$960K | ﹤0.01% | 1863 |
|
|
2023
Q1 | $6.16M | Sell |
201,141
-29,167
| -13% | -$893K | ﹤0.01% | 1772 |
|
|
2022
Q4 | $9.01M | Sell |
230,308
-12,649
| -5% | -$495K | ﹤0.01% | 1561 |
|
|
2022
Q3 | $11.6M | Buy |
242,957
+13,491
| +6% | +$643K | ﹤0.01% | 1392 |
|
|
2022
Q2 | $8.88M | Buy |
229,466
+17,413
| +8% | +$674K | ﹤0.01% | 1582 |
|
|
2022
Q1 | $12.5M | Buy |
212,053
+8,937
| +4% | +$528K | ﹤0.01% | 1500 |
|
|
2021
Q4 | $16.2M | Buy |
203,116
+7,619
| +4% | +$607K | ﹤0.01% | 1362 |
|
|
2021
Q3 | $20.1M | Buy |
195,497
+9,938
| +5% | +$1.02M | 0.01% | 1269 |
|
|
2021
Q2 | $23.9M | Buy |
185,559
+16,429
| +10% | +$2.11M | 0.01% | 1224 |
|
|
2021
Q1 | $13.5M | Sell |
169,130
-33,166
| -16% | -$2.65M | ﹤0.01% | 1607 |
|
|
2020
Q4 | $16.5M | Buy |
202,296
+71,925
| +55% | +$5.87M | 0.01% | 1372 |
|
|
2020
Q3 | $3.21M | Buy |
130,371
+68,697
| +111% | +$1.69M | ﹤0.01% | 2140 |
|
|
2020
Q2 | $1.73M | Buy |
61,674
+15,581
| +34% | +$436K | ﹤0.01% | 2404 |
|
|
2020
Q1 | $830K | Buy |
+46,093
| New | +$830K | ﹤0.01% | 2592 |
|